CLINICAL-LABORATORY, IMMUNOLOGICAL, PATHOGENETIC MANIFESTATIONS OF ANTIPHOSPHOLIPID SYNDROME AND IDENTIFICATION OF EFFECTIVE TREATMENT REGIMENS (REVIEWS)

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/9944

Full metadata record

DC Field	Value	Language
dc.contributor.author	Musakov Mirzokhid Sabitdjanovich, Samatova Lobar Dilmurodovna, Turaxojaeva Sabokhat Sultanshikovna, Salaeva Muborak Saidabdullayevna, Tursunova Minavvar Ulug’bekovna	-
dc.date.accessioned	2024-01-13T19:31:35Z	-
dc.date.available	2024-01-13T19:31:35Z	-
dc.date.issued	2023-05	-
dc.identifier.issn	2751-1731	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/9944	-
dc.description.abstract	Antiphospholipid syndrome (APS) is one of the leading causes of thrombosis. According to some estimates, the incidence of APS is about 5 new cases per 100,000 people per year and the prevalence is about 40-50 cases per 100,000 people [1], thus the problem of APS remains one of the most important in medicine.	en_US
dc.language.iso	en	en_US
dc.publisher	Spectrum Journal of Innovation, Reforms and Development	en_US
dc.subject	antiphospholipid syndrome (APS), antiphospholipid antibodies, lupus anticoagulant.	en_US
dc.title	CLINICAL-LABORATORY, IMMUNOLOGICAL, PATHOGENETIC MANIFESTATIONS OF ANTIPHOSPHOLIPID SYNDROME AND IDENTIFICATION OF EFFECTIVE TREATMENT REGIMENS (REVIEWS)	en_US
dc.type	Article	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
10-174 Статья инглиз.pdf		298.72 kB	Adobe PDF	View/Open

DSpace JSPUI